UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (129519) 129519
Newspaper Article (14125) 14125
Newsletter (2662) 2662
Book Chapter (997) 997
Magazine Article (729) 729
Web Resource (173) 173
Government Document (166) 166
Trade Publication Article (150) 150
Book / eBook (110) 110
Reference (97) 97
Dissertation (96) 96
Conference Proceeding (57) 57
Transcript (54) 54
Report (40) 40
Book Review (31) 31
Publication (28) 28
Journal / eJournal (5) 5
Streaming Video (3) 3
Poster (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (102618) 102618
life sciences & biomedicine (86474) 86474
animals (61317) 61317
humans (59587) 59587
deoxyribonucleic acid--dna (43641) 43641
male (36237) 36237
female (34350) 34350
mice (27321) 27321
dna (22737) 22737
research (20121) 20121
gene expression (20094) 20094
proteins (18517) 18517
oncology (16344) 16344
rats (15861) 15861
research article (15464) 15464
science & technology - other topics (15334) 15334
analysis (15203) 15203
medicine (14543) 14543
multidisciplinary sciences (14195) 14195
cancer (14005) 14005
genetic aspects (13034) 13034
adult (12880) 12880
apoptosis (12626) 12626
genes (12336) 12336
health aspects (12051) 12051
biochemistry & molecular biology (11798) 11798
middle aged (11769) 11769
mutation (11672) 11672
cell biology (11486) 11486
immunology (11389) 11389
dna damage (11322) 11322
science (11309) 11309
polymerase chain reaction (10847) 10847
genomes (9210) 9210
studies (9183) 9183
genetics (9070) 9070
microbiology (8958) 8958
pharmacology & pharmacy (8689) 8689
medicine, research & experimental (8635) 8635
research & experimental medicine (8628) 8628
deoxyribonucleic acid (8550) 8550
dna methylation (8376) 8376
rodents (8331) 8331
physiological aspects (8175) 8175
base sequence (8055) 8055
tumors (7981) 7981
biology and life sciences (7875) 7875
aged (7698) 7698
infectious diseases (7542) 7542
care and treatment (7468) 7468
genetics & heredity (7281) 7281
biology (7280) 7280
mitochondrial dna (7147) 7147
cell line, tumor (7067) 7067
infections (6947) 6947
biochemistry (6891) 6891
genetic research (6796) 6796
medical research (6789) 6789
enzymes (6734) 6734
kinases (6698) 6698
genomics (6696) 6696
molecular sequence data (6591) 6591
physical sciences (6464) 6464
biotechnology & applied microbiology (6391) 6391
abridged index medicus (6366) 6366
mice, inbred c57bl (6196) 6196
oxidative stress (6166) 6166
vaccines (6139) 6139
chemistry (6095) 6095
chemotherapy (5897) 5897
life sciences (5883) 5883
patients (5843) 5843
laboratories (5809) 5809
viruses (5727) 5727
medicine and health sciences (5670) 5670
time factors (5662) 5662
cancer therapies (5651) 5651
cells, cultured (5645) 5645
rna (5605) 5605
neurosciences (5595) 5595
mice, inbred balb c (5493) 5493
signal transduction (5492) 5492
cell cycle (5479) 5479
dose-response relationship, drug (5461) 5461
sequence analysis, dna (5368) 5368
neurosciences & neurology (5289) 5289
disease models, animal (5284) 5284
toxicology (5279) 5279
research and analysis methods (5249) 5249
cell line (5229) 5229
molecular biology (5208) 5208
bacteria (5129) 5129
apoptosis - drug effects (5103) 5103
risk factors (5102) 5102
inflammation (5052) 5052
metabolism (5000) 5000
antigens (4839) 4839
dna repair (4839) 4839
dna - metabolism (4801) 4801
physiology (4759) 4759
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (43) 43
Gerstein Science - Stacks (38) 38
UofT at Mississauga - Stacks (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (12) 12
Robarts - Government Pubs (11) 11
Robarts - Stacks (11) 11
Law (Bora Laskin) - Stacks (10) 10
UofT at Scarborough - Stacks (9) 9
Criminology - Stacks (8) 8
UTL at Downsview - May be requested (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Engineering & Comp. Sci. - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Criminology - Periodical Stacks (1) 1
Gerstein Science - Library use only (1) 1
Gerstein Science - Reference (1) 1
Law (Bora Laskin) - Closed Orders (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - May be requested at Fisher (1) 1
UofT at Mississauga - Periodical Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (147520) 147520
Japanese (932) 932
Russian (551) 551
Chinese (513) 513
German (296) 296
French (198) 198
Portuguese (177) 177
Spanish (114) 114
Polish (59) 59
Norwegian (39) 39
Italian (36) 36
Dutch (32) 32
Korean (28) 28
Hungarian (18) 18
Czech (16) 16
Turkish (13) 13
Ukrainian (11) 11
Swedish (9) 9
Croatian (8) 8
Danish (8) 8
Arabic (3) 3
Persian (3) 3
Indonesian (2) 2
Romanian (2) 2
Urdu (2) 2
Bulgarian (1) 1
Finnish (1) 1
Hebrew (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial agents and chemotherapy, ISSN 1098-6596, 05/2012, Volume 56, Issue 5, pp. 2305 - 2313
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 12/2009, Volume 27, Issue 35, pp. 5874 - 5880
Purpose The standard of care for anaplastic gliomas is surgery followed by radiotherapy. The NOA-04 phase III trial compared efficacy and safety of... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Procarbazine - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lomustine - adverse effects | Middle Aged | Brain Neoplasms - pathology | DNA Repair Enzymes - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Alkylating - administration & dosage | Glioma - radiotherapy | Glioma - genetics | Young Adult | DNA Methylation | Time Factors | Radiotherapy, Adjuvant - adverse effects | Glioma - pathology | Treatment Failure | Tumor Suppressor Proteins - genetics | Dacarbazine - analogs & derivatives | Vincristine - administration & dosage | Adult | Female | Brain Neoplasms - mortality | Chemotherapy, Adjuvant | Brain Neoplasms - radiotherapy | Promoter Regions, Genetic | Dacarbazine - administration & dosage | Glioma - mortality | Drug Administration Schedule | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Brain Neoplasms - drug therapy | Disease Progression | Disease-Free Survival | DNA Modification Methylases - genetics | Procarbazine - adverse effects | Vincristine - adverse effects | Aged | Mutation | Antineoplastic Agents, Alkylating - adverse effects | Lomustine - administration & dosage | Glioma - drug therapy | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 01/2015, Volume 16, Issue 1, pp. 87 - 97
Summary Background The poly(ADP-ribose) polymerase inhibitor olaparib has shown antitumour activity in patients with platinum-sensitive, recurrent, high-grade... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Piperazines - administration & dosage | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - administration & dosage | Ovarian Neoplasms - mortality | Molecular Targeted Therapy | Enzyme Inhibitors - administration & dosage | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Time Factors | Antineoplastic Agents - adverse effects | Adult | Female | Neoplasms, Cystic, Mucinous, and Serous - drug therapy | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Enzyme Inhibitors - adverse effects | Neoplasms, Cystic, Mucinous, and Serous - pathology | Phthalazines - administration & dosage | Drug Administration Schedule | Administration, Oral | Neoplasm Recurrence, Local | Carboplatin - administration & dosage | Neoplasms, Cystic, Mucinous, and Serous - enzymology | Treatment Outcome | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors | Ovarian Neoplasms - enzymology | BRCA1 Protein - genetics | Disease-Free Survival | Administration, Intravenous | Poly(ADP-ribose) Polymerases - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Mutation | BRCA2 Protein - genetics | Neoplasms, Cystic, Mucinous, and Serous - mortality | Phthalazines - adverse effects | Relapse | Chemotherapy | Hospitals | Gene mutations | Sugars | Diseases | Cancer | Monosaccharides | Ovarian cancer | Index Medicus
Journal Article
International journal of oncology, ISSN 1019-6439, 01/2017, Volume 50, Issue 1, pp. 223 - 231
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2015, Volume 16, Issue 13, pp. 1306 - 1315
Summary Background In the TRIBE study, FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus bevacizumab significantly improved... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Leucovorin - administration & dosage | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Bevacizumab - therapeutic use | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Angiogenesis Inhibitors - therapeutic use | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Bevacizumab - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Intention to Treat Analysis | Italy | Aged | Infusions, Intravenous | Mutation | Colorectal Neoplasms - pathology | Antimitotic agents | Cancer patients | Care and treatment | Patient outcomes | Analysis | Colorectal cancer | Leucovorin | Metastasis | Antineoplastic agents | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2015, Volume 16, Issue 13, pp. 1389 - 1398
Summary Background In the COMBI-v trial, patients with previously untreated BRAF Val600Glu or Val600Lys mutant unresectable or metastatic melanoma who were... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prospective Studies | Skin Neoplasms - drug therapy | Oximes - adverse effects | Humans | Oximes - administration & dosage | Protein Kinase Inhibitors - adverse effects | Indoles - administration & dosage | Time Factors | DNA Mutational Analysis | Imidazoles - therapeutic use | MAP Kinase Kinase Kinases - antagonists & inhibitors | Genetic Predisposition to Disease | Administration, Oral | Imidazoles - adverse effects | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | Risk Factors | MAP Kinase Kinase Kinases - metabolism | Disease Progression | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Protein Kinase Inhibitors - administration & dosage | Phenotype | Indoles - adverse effects | Intention to Treat Analysis | Quality of Life | Indoles - therapeutic use | Biomarkers, Tumor - genetics | Pyrimidinones - administration & dosage | Mutation | Sulfonamides - administration & dosage | Melanoma - mortality | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Imidazoles - administration & dosage | Oximes - therapeutic use | Pyridones - administration & dosage | Melanoma - genetics | Skin Neoplasms - mortality | Surveys and Questionnaires | Skin Neoplasms - pathology | Drug Administration Schedule | Treatment Outcome | Melanoma - secondary | Disease-Free Survival | Sulfonamides - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Skin Neoplasms - genetics | Sulfonamides - adverse effects | Pyridones - therapeutic use | Pyridones - adverse effects | Care and treatment | Hospitals | Metastasis | Gene mutations | Comparative analysis | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 05/2012, Volume 30, Issue 15, pp. 1755 - 1762
Journal Article
Biomaterials, ISSN 0142-9612, 10/2017, Volume 141, pp. 86 - 95
Journal Article